Skip to content
Meridian research

Weekly research, verified before it publishes

One free report a week, on one under-radar public equity — picked and written by an automated research process, verified against real financial data before publication. Research process output, not investment advice, and never a buy, sell or hold call.

Reports cover small and micro-cap companies, which can be illiquid and can lose most or all of their value.

All reports
Week of September 21, 2026 · Technology · SemiconductorsAIP· NASDAQ

Arteris Inc.: revenue up 46% in the latest quarter with $8.5M of operating cash flow

Arteris Inc. reported 46% year-over-year revenue growth in the most recent quarter and generated $8.5M in operating cash flow over the trailing 12 months.

Price
24.17 USD+8.4%
Market cap
$1.2B
Revenue, trailing 12mo
$84.6M
Operating cash flow, TTM
$8.5M
4.5/10
Meridian Signal Score
Growth9.6
Valuation1.0
Balance sheet6.9
Stability4.2
Insider buying1.0

Meridian Signal Score: the unweighted average of the 1-10 factor scores that could be computed from the figures in this report (Growth, Valuation, Balance sheet, Stability, Insider buying) - not a proprietary black-box model, and not a recommendation to buy, sell, or hold. 5 of 5 factors scored this week.

Key flags

Loss-making: net loss of $39.5M (trailing 12 months)

Earnings-based multiples such as P/E are not meaningful while earnings are negative.

Fell 58% from peak to trough in the past ~18 months

Largest peak-to-trough decline in the price history on file and has not recovered.

Net insider selling of $70.3M

99 sales by 8 insiders (transactions on file, 2026-05-18 to 2026-09-14).

Operating cash flow is positive

$8.5M generated from operations over the trailing 12 months.

Revenue growing 46% year over year

Most recent quarter versus the same quarter a year earlier.

Revenue up 22% in the fiscal year ended 2025-12-31

$70.6M against $57.7M the year before, from the annual income statements.

High volatility: 88% annualized

Based on the last 90 trading days.

Trades below its 50-day and 200-day averages

Price $24.17 versus $26.79 (50-day) and $24.26 (200-day).

Most recent SEC filing
144 · filed 2026-09-14